© Boehringer Ingelheim, Dieter Quant American biotech, pharmaceutical, and life science companies face many challenges today. Organizations are struggling with a shortage of skilled workers, rising costs, supply chain disruptions,
Nag-atubang sa taas nga inflation, jittery nga mga merkado, ug mga account sa pagretiro nga nameligro, daghang mga tigulang ang gusto ug kinahanglan nga magtrabaho og dugay. Ang mga nagpatrabaho,
Amid the uncertainty of the economy and the world around us, managing difficult questions is an ongoing part of a leader’s job. In this piece, the author outlines strategies to
The months and years ahead will test whether American companies live up to their ESG and corporate social responsibility commitments as we head into recession. The authors, members of three
Sa bag-ohay nga mga tuig, ang AI nahimong mas gamhanan ug ang mga aplikasyon niini sa negosyo miuswag pag-ayo. Ingon usa ka sangputanan, ang mga kompanya nga wala seryoso nga
A worker hotline that is well designed and used by employees not only helps managers detect harm; it can also allow managers to shift from a reactive to a proactive
Todd Pruzan, HBR Welcome to HBR Video Quick Take. I’m Todd Pruzan, senior editor for research and special projects at the Harvard Business Review. Emerson, the global technology, software, and
For half of the world’s population, menopause is a natural part of life. It also happens to overlap exactly with the age at which employees are most likely to be
Economic uncertainty, social and political unrest, environmental catastrophe, and global health crises continue to impact people and businesses worldwide. Yet, amidst each of these disruptions, managers must maintain forward momentum
Top Thoughts for November 24, 2022 IShared DEAS has the power to expand perspectives, change thinking, and move lives. Here are two ideas for the curious mind to engage: I